Binding Kinetics of ZM241385 Derivatives at the Human Adenosine A2AReceptor
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Binding Kinetics of ZM241385 Derivatives at the Human Adenosine A2AReceptor
Authors
Keywords
-
Journal
ChemMedChem
Volume 9, Issue 4, Pages 752-761
Publisher
Wiley
Online
2014-03-04
DOI
10.1002/cmdc.201300474
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel adenosine A2A receptor ligands: A synthetic, functional and computational investigation of selected literature adenosine A2A receptor antagonists for extending into extracellular space
- (2013) Manuela Jörg et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Functional efficacy of adenosine A2A receptor agonists is positively correlated to their receptor residence time
- (2012) Dong Guo et al. BRITISH JOURNAL OF PHARMACOLOGY
- Structure and dynamics of the M3 muscarinic acetylcholine receptor
- (2012) Andrew C. Kruse et al. NATURE
- Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions
- (2012) W. Liu et al. SCIENCE
- Synthesis, molecular structure, NMR spectroscopic and computational analysis of a selective adenosine A2A antagonist, ZM 241385
- (2012) Manuela Jörg et al. STRUCTURAL CHEMISTRY
- Adenosine A2A Receptor Antagonists and Parkinson’s Disease
- (2011) Brian C. Shook et al. ACS Chemical Neuroscience
- Target–drug interactions: first principles and their application to drug discovery
- (2011) Sara Núñez et al. DRUG DISCOVERY TODAY
- International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors--An Update
- (2011) B. B. Fredholm et al. PHARMACOLOGICAL REVIEWS
- Pathway and mechanism of drug binding to G-protein-coupled receptors
- (2011) Ron O. Dror et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure of an Agonist-Bound Human A2A Adenosine Receptor
- (2011) F. Xu et al. SCIENCE
- Recent developments in adenosine receptor ligands and their potential as novel drugs
- (2010) Christa E. Müller et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Binding kinetics and mechanism of action: toward the discovery and development of better and best in class drugs
- (2010) Rumin Zhang et al. Expert Opinion on Drug Discovery
- Efficacy is a contributing factor to the clinical onset of bronchodilation of inhaled β2-adrenoceptor agonists
- (2010) Elizabeth M. Rosethorne et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Fast on-rates allow short dwell time ligands to activate T cells
- (2010) C. C. Govern et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SAR of a series of inhaled A2A agonists and comparison of inhaled pharmacokinetics in a preclinical model with clinical pharmacokinetic data
- (2009) Simon J. Mantell et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Early integration of pharmacokinetic and dynamic reasoning is essential for optimal development of lead compounds: strategic considerations
- (2009) Johan Gabrielsson et al. DRUG DISCOVERY TODAY
- Exploring the Mechanism of Agonist Efficacy: A Relationship between Efficacy and Agonist Dissociation Rate at the Muscarinic M3 Receptor
- (2009) D. A. Sykes et al. MOLECULAR PHARMACOLOGY
- An aqueous medium synthesis and tautomerism study of 3(5)-amino-1,2,4-triazoles
- (2009) Anton V. Dolzhenko et al. TETRAHEDRON LETTERS
- Inhaled adenosine A2A receptor agonists for the treatment of chronic obstructive pulmonary disease
- (2008) Simon J. Mantell et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started